[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354127-105":3,"doc-detail-354127-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","impact-of-physical-frailty-on-early-intolerance-to-capox-chemotherapy-in-patients-with-colon-rectal-and-gastric-cancer","Impact of Physical Frailty on Early Intolerance to CAPOX Chemotherapy in Patients With Colon, Rectal, and Gastric Cancer","","Background: Patients with gastrointestinal cancer often develop frailty that can increase the risk of early chemotherapy intolerance. This study examined whether physical frailty is associated with early intolerance to CAPOX (capecitabine plus oxaliplatin) in patients with colon, rectal, or gastric cancer. Methods: A single-center observational design assessed frailty via the Fried criteria and evaluated early intolerance defined by toxicity-driven dose reduction, delay, regimen change, or discontinuation within the first three cycles. Results: Among 82 patients, 57% showed early intolerance; accumulating frailty criteria increased risk, and gait speed plus exhaustion independently predicted intolerance. Conclusion: Frailty status was not categorically linked to early toxicity, but the accumulation of criteria—and gait speed in particular—was.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/impact-of-physical-frailty-on-early-intolerance-to-capox-chemotherapy-in-patients-with-colon-rectal-and-gastric-cancer/354127/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/impact-of-physical-frailty-on-early-intolerance-to-capox-chemotherapy-in-patients-with-colon-rectal-and-gastric-cancer/354127.png","ImageObject",300,407,{"name":42,"@type":43},"Putri","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study investigate about CAPOX chemotherapy intolerance?","Question",{"text":63,"@type":64},"The study investigates whether physical frailty is associated with early intolerance to CAPOX in patients with colon, rectal, or gastric cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was early chemotherapy intolerance defined?",{"text":68,"@type":64},"Early intolerance was defined as toxicity-related dose reduction, cycle delay, regimen change, or treatment discontinuation within the first three CAPOX cycles.",{"name":70,"@type":61,"acceptedAnswer":71},"Which frailty factors were linked to higher risk of early intolerance?",{"text":72,"@type":64},"The accumulation of physical frailty criteria increased intolerance risk, and both self-reported exhaustion and reduced gait speed independently predicted higher risk.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354127,1790217866,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0",8,"Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nImpact of Physical Frailty on Early Intolerance to CAPOX Chemotherapy in Patients With Colon, Rectal, and Gastric Cancer  \nIsabella Pellegrini Grama Pereira Lima1  | Nicolle Martins Carrozzi1  | Talita Oliveira Silva1  | Karina Almeida de Brunheroti1,2  | Joyce Lucchesi1  | Andréia Cristina Dalbello Rissati3  |  \nLucinea Valério de Almeida Castro3  | Maria Carolina Santos Mendes3,4  | José Barreto Campello Carvalheira3  | Lígia M. Antunes-Correa1   \n1Laboratory of Exercise Physiology (FISEX), Faculty of Physical Education (FEF), University of Campinas (UNICAMP), Campinas, Brazil | 2Jaguariúna University Center (UniFAJ), São Paulo, Brazil | 3Department of Anesthesiology, Oncology and Radiology, School of Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, Brazil | 4Department of Internal Medicine, Faculty of Medical Sciences (FCM), State, University of Campinas (UNICAMP), Campinas, Brazil  \nCorrespondence: Lígia M. Antunes-Correa ([ligiamac@unicamp.br](ligiamac@unicamp.br))  \nReceived: 21 July 2025 | Revised: 6 February 2026 | Accepted: 27 March 2026  \nKeywords: colorectal cancer | early-intolerance | gait speed | gastric cancer | physical frailty | toxicity  \nABSTRACT  \nBackground: Patients with gastrointestinal cancer often present reduction in functional capacity and develop frailty, which increases the risk of chemotherapy intolerance. We investigated whether physical frailty is associated with early intolerance to CAPOX (capecitabine+oxaliplatin) in patients with colon, rectal, or gastric cancer.  \nMethods: This single-center observational study included patients from the Oncogeriatrics Outpatient Clinic at Clinical Hospital at UNICAMP between October 2021 and July 2024. Data included physical, clinical, and anthropometric measures. Frailty was assessed using the Fried criteria, along with planned and modified chemotherapy regimens. Early chemotherapy intolerance was defined as dose reduction, cycle delay, regimen change, or treatment discontinuation due to toxicity within the first three CAPOX cycles. Patients were classified as with or without early chemotherapy-related intolerance.  \nResults: Of 82 patients, 47 (57%) showed early intolerance to treatment. These patients were older, more frequently female, and smokers; no significant differences were observed in anthropometric and oncological variables, or in frailty criteria classification. The number of frailty criteria was associated with increased risk of intolerance (OR = 2.07; CI: 1.14–3.75; p = 0.01). Among individual components, self-reported exhaustion and reduced gait speed independently predicted higher risk (OR = 6.04; CI: 1.62–22.55; p = 0.007), while higher gait speed was protective (OR = 0.05; CI: 0.005–0.61; p = 0.01) .  \nConclusion: Categorical physical frailty status was not associated with early toxicity in our cohort. However, the accumulation of physical frailty criteria showed a significant association with early toxicity. Among these criteria, gait speed emerged as oneof the most relevant predictors of early toxicity in patients with colon, rectal, or gastric cancer treated with CAPOX. Objective assessment of the physical domain should be prioritized over subjective measures to improve treatment decisions and minimize adverse effects. Further research is needed to define standardized protocols for evaluating physical frailty in cancer patients. Précis: Accumulation of physical frailty criteria was significantly associated with early CAPOX intolerance in gastrointestinal cancer patients, with gait speed emerging as an independent predictor of intolerance. Implementing standardized frailty assessment may enhance treatment decision-making by optimizing chemotherapy planning and reducing adverse effects.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the ","cbCaig0Y6JghMZtz","https://ap.wps.com/l/cbCaig0Y6JghMZtz","pdf",720920,11,"English","# Introduction\n## Rationale and CAPOX toxicity\n# Methods\n## Study design and population\n## Frailty assessment and intolerance definition\n# Results\n## Early intolerance frequency\n## Risk association with frailty criteria and components\n# Conclusion\n## Key predictors and implications","[{\"question\":\"What does the study investigate about CAPOX chemotherapy intolerance?\",\"answer\":\"The study investigates whether physical frailty is associated with early intolerance to CAPOX in patients with colon, rectal, or gastric cancer.\"},{\"question\":\"How was early chemotherapy intolerance defined?\",\"answer\":\"Early intolerance was defined as toxicity-related dose reduction, cycle delay, regimen change, or treatment discontinuation within the first three CAPOX cycles.\"},{\"question\":\"Which frailty factors were linked to higher risk of early intolerance?\",\"answer\":\"The accumulation of physical frailty criteria increased intolerance risk, and both self-reported exhaustion and reduced gait speed independently predicted higher risk.\"}]","Impact of Physical Frailty on Early Intolerance to CAPOX Chemotherapy in Patients With Colon, Rectal, and Gastric Cancer | PDF",1790109126,28,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad55752499341efa37a326c1c2fe9332.webp",983,1291,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/387b71b23ef08ceaf65b0617b299f3c8.webp",982,1290,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6b1ca256523d0c443749d887ca86e1c.webp",981,1289,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30a0b5f1a3d7db61b714eead7fbfb051.webp",980,1287,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,160],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":157,"doc_module":4,"doc_module_name":25,"category_name":158,"show_sort_weight":157,"slug":159},10,"Lifestyle","lifestyle",{"id":161,"doc_module":4,"doc_module_name":25,"category_name":162,"show_sort_weight":131,"slug":163},19,"General","general"]